Newsletter | November 19, 2026

11.19.26 -- RWE, AI Agents, And The Work Of Building Better Trials

WHERE REAL-WORLD EVIDENCE EARNS ITS PLACE

Where Real-World Data Adds Value Alongside Clinical Trials

Biostatistician Natasa Rajicic explains where RWD supports development and safety monitoring, and why replacing randomized comparators remains challenging.

 

How HEOR Teams Build Real-World Evidence That Stands Up

Jessica Jalbert explains how fit-for-purpose data, prespecified analyses, and transparent methods strengthen RWE for regulators, payers, and clinicians.

A SPONSOR’S GUIDE TO PUTTING RWD TO WORK

Turning RWD Into RWE: A Practical Guide For Trial Sponsors

Learn how to assess data quality, protect patient privacy, and apply RWD to site selection, enrollment, and trial design while planning for regulatory review.

CONNECTING EVIDENCE, AI, AND TRIAL EXECUTION

AI Agents In Clinical Trials: Governance, Validation, And Value

Explore agentic AI in trials, from ontologies and human oversight to continuous validation and the practical trade-offs of building versus buying.

Why Connecting IRT, eCOA, And Trial Supply Reduces Risk

Disconnected IRT, eCOA, and clinical supply workflows can create trial risks. Explore what sponsors need to consider when connecting these functions.

Why Site Digitization Starts With Simpler Workflows

Explore how clearer document ownership, easier training access, and fewer duplicate tasks can reduce site burden without a sweeping technology overhaul.

PMCF Planning: Match Clinical Evidence Gaps To Methods

Explore how to choose PMCF methods, assess costs, and address notified body expectations while accounting for proposed EU reporting changes.

The Human Impact Of Clinical Trials Beyond The Data

A research leader reflects on personal experiences of treatment breakthroughs and loss, highlighting the patients, families, and teams behind clinical trials.

PRACTICAL TOOLS FOR STUDY SETUP AND DECISION-MAKING

Live AI Demo: From Study Setup To Validation-Ready In 15 Minutes

Governing AI Decisions Across Clinical Trial Workflows

Choosing Clinical Trial Vendors Before A New Study Starts